In 2006, Lithuania initiated an organised nationwide PSA-based Early Prostate Cancer Detection Programme (EPCDP) operating on an opportunistic approach, targeting its 2.8 million inhabitants in 2019. The gene discussed is KLK3; the disease is prostate cancer.